Efficiency of Cell-Free and Cell-Associated Virus in Mucosal Transmission of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

被引:53
|
作者
Kolodkin-Gal, Dror [1 ,2 ]
Hulot, Sandrine L. [1 ]
Korioth-Schmitz, Birgit [1 ]
Gombos, Randi B. [1 ]
Zheng, Yi [1 ]
Owuor, Joshua [1 ]
Lifton, Michelle A. [1 ]
Ayeni, Christian [1 ]
Najarian, Robert M. [1 ]
Yeh, Wendy W. [1 ]
Asmal, Mohammed [1 ]
Zamir, Gideon [2 ]
Letvin, Norman L. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Hadassah Hebrew Univ, Med Ctr, Dept Expt Surg, Jerusalem, Israel
关键词
TROJAN HORSE LEUKOCYTES; CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; VAGINAL TRANSMISSION; RHESUS MACAQUES; SEMINAL PLASMA; SEMEN; AIDS; SIV;
D O I
10.1128/JVI.03108-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Effective strategies are needed to block mucosal transmission of human immunodeficiency virus type 1 (HIV-1). Here, we address a crucial question in HIV-1 pathogenesis: whether infected donor mononuclear cells or cell-free virus plays the more important role in initiating mucosal infection by HIV-1. This distinction is critical, as effective strategies for blocking cell-free and cell-associated virus transmission may be different. We describe a novel ex vivo model system that utilizes sealed human colonic mucosa explants and demonstrate in both the ex vivo model and in vivo using the rectal challenge model in rhesus monkeys that HIV-1-infected lymphocytes can transmit infection across the mucosa more efficiently than cell-free virus. These findings may have significant implications for our understanding of the pathogenesis of mucosal transmission of HIV-1 and for the development of strategies to prevent HIV-1 transmission.
引用
收藏
页码:13589 / 13597
页数:9
相关论文
共 50 条
  • [21] Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection
    Terrazas-Aranda, Katty
    Van Herrewege, Yven
    Hazuda, Daria
    Lewi, Paul
    Costi, Roberta
    Di Santo, Roberto
    Cara, Andrea
    Vanham, Guido
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) : 2544 - 2554
  • [22] DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus
    Pöhlmann, S
    Baribaud, F
    Lee, B
    Leslie, GJ
    Sanchez, MD
    Hiebenthal-Millow, K
    Münch, J
    Kirchhoff, F
    Doms, RW
    JOURNAL OF VIROLOGY, 2001, 75 (10) : 4664 - 4672
  • [23] Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2
    Biberfeld, G
    Thorstensson, R
    Putkonen, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (05) : 443 - 446
  • [24] Impact of Mucosal Inflammation on Oral Simian Immunodeficiency Virus Transmission
    Giavedoni, Luis D.
    Chen, Hui-Ling
    Hodara, Vida L.
    Chu, Lianrui
    Parodi, Laura M.
    Smith, Lisa M.
    Sexton, Valerie
    Cappelli, David
    Sodora, Donald L.
    JOURNAL OF VIROLOGY, 2013, 87 (03) : 1750 - 1758
  • [25] Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections
    Overbaugh, J
    Luciw, PA
    Hoover, EA
    AIDS, 1997, 11 : S47 - S54
  • [26] Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2
    Howe, AYM
    Jung, JU
    Desrosiers, RC
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 9827 - 9834
  • [27] ORAL INFECTION OF NEONATAL RHESUS-MONKEYS WITH CELL-FREE SIMIAN IMMUNODEFICIENCY VIRUS
    BABA, TW
    KOCH, JA
    GREENE, MF
    WYAND, MS
    PENNINCK, D
    RUPRECHT, RM
    PEDIATRIC RESEARCH, 1994, 35 (04) : A293 - A293
  • [28] Virus and target cell evolution in human immunodeficiency virus type 1 infection
    Donald E. Mosier
    Immunologic Research, 2000, 21 : 253 - 258
  • [29] Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation
    MacLean, AG
    Rasmussen, TA
    Bieniemy, D
    Lackner, AA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 750 - 752
  • [30] Virus and target cell evolution in human immunodeficiency virus type 1 infection
    Mosier, DE
    IMMUNOLOGIC RESEARCH, 2000, 21 (2-3) : 253 - 258